These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 34748868)
21. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation. Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748 [TBL] [Abstract][Full Text] [Related]
22. In vitro, In silico and In vivo Antitumor Activity of Crude Methanolic Extract of Tetilla dactyloidea (Carter, 1869) on DEN Induced HCC in a Rat Model. Krishnan GS; Rajagopal V; Antony Joseph SR; Sebastian D; Savarimuthu I; Selvaraj KRN; Thobias AF Biomed Pharmacother; 2017 Nov; 95():795-807. PubMed ID: 28892791 [TBL] [Abstract][Full Text] [Related]
23. Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis. Wei J; Ma L; Liu W; Wang Y; Shen C; Zhao X; Zhao C J Ethnopharmacol; 2021 Aug; 276():114174. PubMed ID: 33932512 [TBL] [Abstract][Full Text] [Related]
24. Aidi injection altered the activity of CYP2D4, CYP1A2, CYP2C19, CYP3A2, CYP2E1 and CYP2C11 in normal and diethylnitrosamine-induced hepatocellular carcinoma in rats. Lu Y; Wang Y; He Y; Pan J; Jin Y; Zheng L; Huang Y; Li Y; Liu W J Ethnopharmacol; 2022 Mar; 286():114930. PubMed ID: 34952190 [TBL] [Abstract][Full Text] [Related]
25. Regulation of Fuzheng Huayu capsule on inhibiting the fibrosis-associated hepatocellular carcinogenesis. Zhang WQ; Sun JX; Lan ST; Sun XM; Guo YJ; Wen BC; Chen J; Liu G J Asian Nat Prod Res; 2024 Oct; 26(10):1219-1238. PubMed ID: 38780602 [TBL] [Abstract][Full Text] [Related]
26. Anti cancerous efficacy of Ayurvedic milk extract of Semecarpus anacardium nuts on hepatocellular carcinoma in Wistar rats. Joseph JP; Raval SK; Sadariya KA; Jhala M; Kumar P Afr J Tradit Complement Altern Med; 2013; 10(5):299-304. PubMed ID: 24311839 [TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin gallate induces chemopreventive effects on rats with diethylnitrosamine‑induced liver cancer via inhibition of cell division cycle 25A. Tang Y; Cao J; Cai Z; An H; Li Y; Peng Y; Chen N; Luo A; Tao H; Li K Mol Med Rep; 2020 Nov; 22(5):3873-3885. PubMed ID: 33000276 [TBL] [Abstract][Full Text] [Related]
28. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858 [TBL] [Abstract][Full Text] [Related]
29. Identification of potential targets with high centrality indicated by diethylnitrosamine + thioacetamide-induced hepatocellular carcinoma model. Hora S; Asad M; Jain SK; Katare DP J Cancer Res Ther; 2021; 17(4):1081-1092. PubMed ID: 34528568 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma. Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037 [TBL] [Abstract][Full Text] [Related]
31. p53-p66(shc)/miR-21-Sod2 signaling is critical for the inhibitory effect of betulinic acid on hepatocellular carcinoma. Yang J; Qiu B; Li X; Zhang H; Liu W Toxicol Lett; 2015 Nov; 238(3):1-10. PubMed ID: 26222667 [TBL] [Abstract][Full Text] [Related]
32. Exploring the mechanism of Jianpi Huatan recipe in protecting hepatocellular carcinoma based on network pharmacology. Zhang C; Xiang H; Wang J; Shao G; Ding P; Gao Y; Xu H; Ji G; Wu T J Ethnopharmacol; 2023 Dec; 317():116676. PubMed ID: 37279814 [TBL] [Abstract][Full Text] [Related]
33. Qingdu decoction can reduce LPS induced ACLF endotoxemia by regulating microRNA-34c/MAZ/TJs and microRNA-122a/Zonulin/EGFR signal pathway. Gou W; Zhang D; Gao L J Ethnopharmacol; 2023 Feb; 302(Pt B):115922. PubMed ID: 36414212 [TBL] [Abstract][Full Text] [Related]
36. Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice. Yi X; Long L; Yang C; Lu Y; Cheng M PLoS One; 2014; 9(4):e93599. PubMed ID: 24690765 [TBL] [Abstract][Full Text] [Related]
37. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling. Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116 [TBL] [Abstract][Full Text] [Related]
38. Molecular Changes Following Induction of Hepatocellular Carcinoma by Diethylnitrosamine and Thioacetamide, and Subsequent Treatment with Kerdput V; Kanjanapongkul K; Itharat A; Pramong R; Lamers WH; Hakvoort TBM; Jongejan A; Pradidarcheep W Int J Med Sci; 2022; 19(12):1806-1815. PubMed ID: 36313224 [TBL] [Abstract][Full Text] [Related]
39. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394 [TBL] [Abstract][Full Text] [Related]
40. Suppression of hepatic tumor growth and metastasis by metronomic therapy in a rat model of hepatocellular carcinoma. Jang JW; Park ST; Kwon JH; You CR; Choi JY; Jung CK; Bae SH; Yoon SK Exp Mol Med; 2011 May; 43(5):305-12. PubMed ID: 21483229 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]